Condition: Psychosis Associated With Alzheimer's Disease · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
This is a Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of KarXT in male and female subjects who are aged 55 to 90 years and have mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD. The primary objective of the study is to evaluate the efficacy of KarXT compared with placebo in the treatment of subjects with psychosis associated with AD as measured by the Neuropsychiatric Inventory-Clinician (NPI-C): Hallucinations and Delusions (H+D) score.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 1116 | Chandler, Arizona, United States | Active Not Recruiting |
| Local Institution - 1044 | Phoenix, Arizona, United States | Active Not Recruiting |
| Local Institution - 1104 | Anaheim, California, United States | Active Not Recruiting |
| Local Institution - 1119 | Canoga Park, California, United States | Active Not Recruiting |
| Local Institution - 1151 | Encino, California, United States | Active Not Recruiting |
| Local Institution - 1142 | Lancaster, California, United States | Active Not Recruiting |
| Local Institution - 1117 | Los Alamitos, California, United States | Active Not Recruiting |
| Local Institution - 1103 | Sherman Oaks, California, United States | Active Not Recruiting |
| Local Institution - 1007 | Walnut Creek, California, United States | Active Not Recruiting |
| Local Institution - 1160 | Apopka, Florida, United States | Withdrawn |
| Local Institution - 1156 | Clermont, Florida, United States | Active Not Recruiting |
| Local Institution - 1138 | Cutler Bay, Florida, United States | Active Not Recruiting |
+ 142 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06126224